PrecisionIR.com

Home » About Us » Company Highlights

Biotechnology & Healthcare Executives will Present to Investors and Respond to Questions at Investor Forum in San Francisco on December 7

Presenting Companies Include Nektar Therapeutics, Avant Immunotherapeutics, Inc., Stem Cell Therapeutics Corp. Biosante Pharmaceuticals, Inc., ADVENTRX Pharmaceuticals, Inc., Aeolus Pharmaceuticals, Inc., and Resverlogix Corporation

Richmond, VA – December 1, 2005 – PrecisionIR, from WILink plc (LSE: WLK.L), a worldwide provider of web-based communication solutions and online investor relations services will host an Informed Investors forum on Wednesday, December 7 in San Francisco. Current and prospective investors will hear top executives from 15 diverse companies in the Life Sciences field present their unique stories at the forum which will be held at The Hyatt Regency at 5 Embarcadero Center, San Francisco starting at 8:30am PST.

The analyst-style forum is open to the investing public and will include a question and answer session with each company executive. Along with hearing directly from the executives, investors will also have access to a comprehensive Panel Discussion involving analysts, industry executives and members of the media.

Participants in the Panel Discussion include experienced biotechnology analysts, such as John McCamant, Editor of The Medical Technology Stock Letter, Dr. Adam Noah, Vice President Biotechnology Equity Research with Merriman Curhan Ford & Co., Dr. Charles Duncan, Managing Director at JMP Securities LLC, Daniel Levine with San Francisco Business Times, and Mark Veverka with Barron’s.

Investors must register to attend the Biotechnology & Healthcare Forum in San Francisco at http://www.investorcalendar.com/IIF/CustomEvent/90563/index.asp. Additional information about the event is also available at the Informed Investors website: www.informedinvestors.com. The event is sponsored by Barron’s, The Wall Street Journal, and Business Wire is the event News Distribution Sponsor.

“This forum will provide investors in the Biotechnology and Healthcare sectors a unique opportunity for direct access to important information,” said J. Patrick Galleher, chief executive officer of WILink, plc. “Typically, financial analysts and professional investors are the only ones who get to look executives in the eye when they answer questions, but our forums help to level the field for all investors.”

Pre-registration is required to attend the event. Registration includes access to all presentations and Q&A sessions, lunch, an investor panel discussion, a networking session, and a forum report with information about each company. Investors may also sign up, at the event, to receive a free 13 week trial of The Wall Street Journal or Barron’s publications.

The presenting companies vary in size, geography and specialization:

Nektar Therapeutics (NasdaqNM: NKTR)

AVANT Immunotherapeutics (NasdaqNM: AVAN)

BioSante Pharmaceuticals Inc. (AMEX: BPA)

Stem Cell Therapeutics (TSX: SSS.V)

Cord Blood America (OTC BB: CBAI.OB)

BioMS Medical Corp. (TSX: MS.TO)

ADVENTRX Pharmaceuticals, Inc. (AMEX: ANX)

Aeolus Pharmaceuticals Inc. (OTC BB: AOLS.OB)

Ceragenix Pharmaceuticals, Inc. (OTC BB: CGXP.OB)

Resverlogix Corporation (TSX: RVX.TO)

EXACT Sciences Corporation (NasdaqNM: EXAS)

Symbollon Pharmaceuticals, Inc. (OTC BB: SYMBA.OB)

Biophan Technologies Inc. (OTC BB: BIPH.OB)

Hana Biosciences, Inc. (AMEX: HBX)

Antares Pharma Inc. (AMEX: AIS)

For more information on these companies and to register for the event, please go to:
http://www.investorcalendar.com/IIF/CustomEvent/90563/index.asp, or contact Cary Loeser at (804) 327-3407, or cloeser@wilink.com.

Informed Investors (www.informedinvestors.com) is a leading provider of online and on-site industry-specific investment conferences for investors, and a member of the PrecisionIR suite of investor relations services from WILink.

Back to News